Background Organ transplant is the preferred treatment for end-stage organ disease, yet the
majority of patients with end-stage organ disease are never placed on the transplant waiting …

Stark racial disparities in access to and receipt of kidney transplantation, especially living
donor and pre-emptive transplantation, have persisted despite decades of investigation and …

Background Fewer minoritized patients with end-stage kidney disease (ESKD) receive
kidney transplantation (KT); efforts to mitigate disparities have thus far failed. Pinpointing the …

Health equity research in transplantation has largely relied on national data sources, yet the
availability of social determinants of health (SDOH) data varies widely among these sources …

Background The kidney is the most needed organ for transplantation in the United States.
However, demand and scarcity of this organ has caused significant inequities for historically …

Importance System and center-level interventions to improve health equity in organ
transplantation benefit from robust characterization of the referral population served by each …

Patients with end stage kidney disease (ESKD) and a previous acute myocardial infarction
(AMI) have less access to KT. Data on ESKD patients with an AMI history who underwent …

Abstract Objectives Blacks and Hispanics face a higher incidence rate of end-stage renal
disease (ESRD) and tend to experience poorer access to quality health care compared with …

Black Americans experience end-stage kidney disease (ESKD) at a disproportionately
higher rate than other racial and ethnic groups in the United States. Kidney transplantation …

Background: Individuals currently living in neighborhoods historically influenced by racial
segregation have reduced access to healthcare. Whether this is true for individuals with end …